Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Ferring Pharmaceuticals Ltd, Drayton Hall, Church Road, West Drayton, UB7 7PS
PABAL 100 micrograms/ml solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. A clear colourless solution. |
Carbetocin 100 micrograms/ml.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Carbetocin |
Carbetocin selectively binds to oxytocin receptors in the smooth muscle of the uterus, stimulates rhythmic contractions of the uterus, increases the frequency of existing contractions, and raises the tone of the uterus musculature. |
| List of Excipients |
|---|
|
L-methionine |
Type I glass vials (2R) with type 1 bromobutyle stoppers with aluminium crimp cap containing 1 ml of solution for injection.
Packs of 5 vials.
Ferring Pharmaceuticals Ltd, Drayton Hall, Church Road, West Drayton, UB7 7PS
PL 03194/0058
5th November 2007
| Drug | Countries | |
|---|---|---|
| PABAL | Austria, Estonia, Finland, France, Ireland, Israel, Lithuania, Nigeria, Netherlands, Poland, Romania, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
